Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 18.94%1.74B | 17.95%1.11B | 17.60%540.94M | -12.34%2B | -19.99%1.46B | -25.65%938.51M | -27.08%459.99M | -7.65%2.29B | -0.79%1.83B | 3.85%1.26B |
| Operating income | 18.94%1.74B | 17.95%1.11B | 17.60%540.94M | -12.34%2B | -19.99%1.46B | -25.65%938.51M | -27.08%459.99M | -7.65%2.29B | -0.79%1.83B | 3.85%1.26B |
| Cost of sales | -16.93%-1.54B | -15.90%-995.39M | -14.08%-490.94M | 0.01%-1.8B | 2.99%-1.32B | 2.96%-858.82M | -0.40%-430.35M | -10.25%-1.8B | -9.61%-1.36B | -4.53%-884.97M |
| Operating expenses | -16.93%-1.54B | -15.90%-995.39M | -14.08%-490.94M | 0.01%-1.8B | 2.99%-1.32B | 2.96%-858.82M | -0.40%-430.35M | -10.25%-1.8B | -9.61%-1.36B | -4.53%-884.97M |
| Gross profit | 37.41%197.46M | 40.04%111.61M | 68.73%50M | -57.89%205.13M | -69.35%143.7M | -78.87%79.7M | -85.34%29.63M | -42.26%487.1M | -22.24%468.88M | 2.27%377.25M |
| Selling expenses | -2.35%-7.18M | -1.55%-4.84M | -11.54%-2.21M | 5.51%-9.63M | 6.58%-7.01M | 6.29%-4.77M | 26.15%-1.99M | 18.25%-10.19M | 21.41%-7.51M | 27.55%-5.09M |
| Administrative expenses | -18.51%-288.28M | -15.91%-190.18M | -23.99%-94.9M | -8.80%-351.28M | -5.54%-243.27M | -10.98%-164.08M | -4.03%-76.54M | -21.08%-322.87M | -9.76%-230.49M | -6.42%-147.84M |
| Revaluation surplus | ---- | ---- | ---- | -137.86%-39K | ---- | ---- | ---- | 32.05%103K | ---- | ---- |
| -Changes in the fair value of investment property | ---- | ---- | ---- | -137.86%-39K | ---- | ---- | ---- | 32.05%103K | ---- | ---- |
| Special items of operating profit | -43.24%76.77M | -25.60%42.62M | -46.72%14.36M | 4.49%115.68M | 1,152.12%135.27M | 1,158.12%57.28M | -18.25%26.94M | 374.20%110.7M | 114.08%10.8M | 113.71%4.55M |
| Operating profit | -173.97%-21.22M | -28.03%-40.8M | -49.28%-32.76M | -115.16%-40.14M | -88.13%28.69M | -113.92%-31.87M | -113.81%-21.94M | -49.48%264.85M | -11.96%241.69M | 31.19%228.88M |
| Financing cost | 22.04%-59.8M | 15.94%-41.55M | 5.22%-23.3M | 3.37%-97.11M | 5.25%-76.71M | 12.82%-49.43M | 13.47%-24.59M | -149.18%-100.5M | ---80.96M | ---56.7M |
| Share of profits of associates | -20.71%3.09M | -55.69%1.24M | -53.79%652K | -62.52%3.46M | 85.86%3.89M | -19.95%2.81M | -7.17%1.41M | -24.16%9.23M | -56.91%2.09M | 52.41%3.5M |
| Earning before tax | -76.63%-77.94M | -3.33%-81.11M | -22.80%-55.41M | -177.08%-133.79M | -127.10%-44.12M | -144.68%-78.5M | -134.18%-45.12M | -65.01%173.58M | -41.72%162.82M | -0.61%175.68M |
| Tax | -473,933.33%-14.22M | -133.60%-3.85M | -83.64%3.25M | 86.02%-6.59M | 100.01%3K | 142.55%11.46M | 122.83%19.83M | 47.31%-47.15M | 31.81%-39.94M | -25.87%-26.95M |
| After-tax profit from continuing operations | -108.86%-92.15M | -26.75%-84.96M | -106.29%-52.16M | -211.04%-140.39M | -135.91%-44.12M | -145.07%-67.03M | -117.95%-25.29M | -68.90%126.43M | -44.35%122.88M | -4.26%148.74M |
| Earning after tax | -108.86%-92.15M | -26.75%-84.96M | -106.29%-52.16M | -211.04%-140.39M | -135.91%-44.12M | -145.07%-67.03M | -117.95%-25.29M | -68.90%126.43M | -44.35%122.88M | -4.26%148.74M |
| Minority profit | -1.69%-129.58M | 8.40%-96.67M | 2.09%-55.91M | -29.22%-198.49M | -4.65%-127.43M | -28.65%-105.53M | -403.92%-57.1M | -254.42%-153.61M | -74.01%-121.77M | -160.16%-82.02M |
| Profit attributable to shareholders | -55.07%37.43M | -69.60%11.7M | -88.21%3.75M | -79.25%58.11M | -65.95%83.31M | -83.32%38.49M | -79.10%31.82M | -37.76%280.03M | -15.86%244.65M | 23.48%230.76M |
| Basic earnings per share | -54.17%0.022 | -68.18%0.007 | -89.47%0.002 | -82.01%0.034 | -74.05%0.048 | -87.50%0.022 | -83.62%0.019 | -45.22%0.189 | -17.41%0.185 | 22.22%0.176 |
| Diluted earnings per share | -54.17%0.022 | -68.18%0.007 | -89.47%0.002 | -81.91%0.034 | -73.91%0.048 | -87.43%0.022 | -83.48%0.019 | -45.03%0.188 | -16.74%0.184 | 23.24%0.175 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.